:GPCR

Patrick M Sexton1, Arthur Christopoulos2

  • 1Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville VIC 3052, Australia; School of Pharmacy, Fudan University, Shanghai 201203, China.

Cell
|February 10, 2018
PubMed
概括

一种药物对多种目标的多药性是精神分裂症等复杂疾病的关键. 了解G蛋白结合受体 (GPCR) 相互作用可以导致新的药物开发策略.